Parathyroid Disease Treatment Global Market Report 2026
상품코드:1957578
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
부갑상선 질환 치료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 23억 7,000만 달러에서 2026년에는 25억 4,000만 달러에 이르고, CAGR 7.2%로 성장할 전망입니다. 지난 몇 년간 부갑상선 기능 항진증 유병률 증가, 부갑상선 질환에 대한 낮은 인지도, 기존 호르몬 대체요법에 대한 의존도, 첨단 수술적 개입의 부족, 병원 약국 인프라의 제약 등이 지난 몇 년간 성장의 원인으로 꼽힙니다.
부갑상선 질환 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 33억 1,000만 달러에 이르고, CAGR은 6.8%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 칼시미메틱 및 비스포스포네이트 제제에 대한 수요 증가, 부갑상선 영상진단 기술의 발전, 재택의료 및 원격의료 솔루션의 확대, 정밀의료에 대한 규제적 지원, 내분비질환 전문 치료센터의 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 칼슘 유사체 및 비스포스포네이트의 채택 증가, 중증 환자에서 경구 투여보다 주사제 투여 선호도 증가, 병원 및 전문 의료시설의 확장, 개별화된 호르몬 대체 요법에 대한 관심 증가, 치료 계획에 생활습관 및 영양 개입의 통합 등이 있습니다.
만성콩팥병(CKD)의 유병률 증가는 향후 몇 년 동안 부갑상선 질환 치료제 시장의 성장을 견인할 것으로 예측됩니다. 만성콩팥병은 신장이 점차 정상적인 기능을 잃어가는 장기적인 질환으로, 칼슘과 인 등 필수 미네랄의 균형을 무너뜨리는 질환입니다. CKD 증가 추세는 주로 당뇨병 발병률 증가에 기인하며, 장기간의 고혈당 상태가 신장의 여과 기능을 점차적으로 손상시켜 당뇨병성 신증을 유발하기 때문입니다. 부갑상선 질환 치료는 이차성 부갑상선 기능 항진증 치료를 통해 CKD 관리에 중요한 역할을 합니다. 이는 진행기에 자주 발생하는 합병증으로 칼슘과 인의 균형을 깨뜨리고, 뼈 질환을 촉진하며, 혈관 석회화를 촉진합니다. 예를 들어, 2024년 5월 미국 질병예방통제센터(CDC)가 발표한 보고서에 따르면, 2023년 기준 미국 성인 7명 중 1명 이상(약 3,550만 명, 14%)이 CKD를 앓고 있으며, 이 중 약 90%가 자신의 병을 인지하지 못하고 있는 것으로 나타났습니다. 따라서 만성 신장 질환의 유병률 증가는 부갑상선 질환 치료 시장의 성장을 가속하고 있습니다.
부갑상선 질환 치료제 시장의 주요 기업들은 부갑상선 기능 저하증 환자의 칼슘 조절을 개선하고 투여 빈도를 줄이기 위한 부갑상선 호르몬(PTH) 프로드러그와 같은 혁신적인 치료법 개발에 집중하고 있습니다. PTH 프로드러그는 체내에서 활성형 부갑상선 호르몬으로 전환되어 칼슘과 인산염의 균형을 회복시키는 불활성 화합물입니다. 예를 들어, 2024년 8월 덴마크에 본사를 둔 바이오 제약기업 Ascendis Pharma A/S는 성인 만성 부갑상선기능저하증 치료제로 PTH(1-34)프로드러그인 YORVIPATH(팔로페그테리파라타이드)의 미국 식품의약국(FDA) 승인을 획득했습니다. 승인 받았습니다. 1일 1회 투여하는 이 치료법은 부갑상선 호르몬을 24시간 동안 지속적으로 노출시켜 근본적인 호르몬 결핍을 직접적으로 해결함으로써 기존의 칼슘 및 비타민D 보충 요법을 대체할 수 있는 대안이 될 수 있습니다. YORVIPATH의 승인은 부갑상선 질환 환자들의 복약 순응도와 임상적 결과를 개선하기 위한 첨단 호르몬 대체요법에 대한 관심이 높아지고 있음을 보여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Parathyroid disease treatment refers to medical and surgical interventions used to manage disorders of the parathyroid glands, which are small endocrine glands located in the neck that regulate calcium and phosphorus levels in the body through the secretion of parathyroid hormone (PTH).
The main types of parathyroid disease treatment include calcimimetics, bisphosphonates, plicamycin, hormone replacement therapy, and other therapies. Calcimimetics are drugs that lower PTH levels by mimicking calcium and activating calcium-sensing receptors on the parathyroid glands. These treatments are administered through various routes, including oral and parenteral, and are distributed via hospital pharmacies, retail pharmacies, and online pharmacies. They are used by a range of end users, including hospitals, homecare settings, specialty centers, and others.
Tariffs have impacted the parathyroid disease treatment market by increasing costs for imported active pharmaceutical ingredients (APIs) and medical devices used in parathyroid therapies. The resulting price surge is affecting segments such as calcimimetics, bisphosphonates, and parenteral administration, particularly in North America and Europe, where imports constitute a significant portion of the supply chain. Hospitals and specialty centers are most affected due to procurement dependence on global suppliers. However, tariffs are also encouraging local manufacturing and innovation, potentially reducing long-term dependency on imports and boosting domestic production capabilities.
The parathyroid disease treatment market research report is one of a series of new reports from The Business Research Company that provides parathyroid disease treatment market statistics, including parathyroid disease treatment industry global market size, regional shares, competitors with a parathyroid disease treatment market share, detailed parathyroid disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid disease treatment industry. This parathyroid disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The parathyroid disease treatment market size has grown strongly in recent years. It will grow from $2.37 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of hyperparathyroidism, limited awareness of parathyroid disorders, dependence on conventional hormone replacement therapy, lack of advanced surgical interventions, constrained hospital pharmacy infrastructure.
The parathyroid disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for calcimimetics and bisphosphonates, advancements in parathyroid imaging and diagnostics, growing homecare and telemedicine solutions, regulatory support for precision medicine, expanding specialty centers for endocrine disorders. Major trends in the forecast period include increasing adoption of calcimimetics and bisphosphonates, rising preference for parenteral over oral administration in severe cases, expansion of hospital and specialty care settings, growing focus on personalized hormone replacement therapies, integration of lifestyle and nutritional interventions in treatment plans.
The rising prevalence of chronic kidney disease (CKD) is expected to drive growth in the parathyroid disease treatment market in the coming years. Chronic kidney disease is a long-term condition in which the kidneys gradually lose their ability to function properly, causing imbalances in essential minerals such as calcium and phosphorus. The increasing prevalence of CKD is largely attributed to the growing incidence of diabetes, as prolonged high blood sugar levels can damage the kidneys' filtering units over time, leading to diabetic nephropathy. Parathyroid disease treatments play a critical role in managing CKD by addressing secondary hyperparathyroidism, a common complication in advanced stages that disrupts calcium and phosphorus balance, contributes to bone disorders, and promotes vascular calcification. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that more than one in seven US adults-approximately 35.5 million people, or 14%-had CKD in 2023, and nearly 90% of them were unaware of their condition. Therefore, the rising prevalence of chronic kidney disease is propelling growth in the parathyroid disease treatment market.
Key companies in the parathyroid disease treatment market are focusing on developing innovative therapies such as parathyroid hormone (PTH) prodrugs to improve calcium regulation and reduce dosing frequency in patients with hypoparathyroidism. PTH prodrugs are inactive compounds that convert into active parathyroid hormone in the body to restore calcium and phosphate balance. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, received US Food and Drug Administration (FDA) approval for YORVIPATH (palopegteriparatide), a PTH [1-34] prodrug for treating chronic hypoparathyroidism in adults. This once-daily therapy provides continuous parathyroid hormone exposure over 24 hours, offering an alternative to conventional calcium and vitamin D supplementation by directly addressing the underlying hormone deficiency. The approval of YORVIPATH highlights the growing emphasis on advanced hormone replacement therapies designed to improve adherence and clinical outcomes for patients with parathyroid disorders.
In July 2024, AstraZeneca PLC, a UK-based biopharmaceutical company, acquired Amolyt Pharma SAS for $1.05 billion. Through this acquisition, AstraZeneca aims to strengthen its Alexion Rare Disease portfolio by advancing its late-stage pipeline and expanding its bone metabolism franchise with eneboparatide (AZP-3601), a Phase III investigational therapy for hypoparathyroidism. Amolyt Pharma SAS is a France-based clinical-stage biotechnology company developing novel treatments for rare endocrine diseases, including parathyroid disorders such as hypoparathyroidism.
Major companies operating in the parathyroid disease treatment market are AstraZeneca PLC, Amgen Inc., Kyowa Kirin Co. Ltd., OPKO Health Inc., Septerna Inc., Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., Crinetics Pharmaceuticals Inc., Vidasym Inc., Rani Therapeutics LLC, Pathalys Pharma Inc.
Asia-Pacific was the largest region in the parathyroid disease treatment market in 2025. The regions covered in the parathyroid disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the parathyroid disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The parathyroid disease treatment market consists of revenues earned by entities by providing services such as diagnostic testing, surgical intervention, hormone level monitoring, post-operative care, and medical management of calcium and phosphate balance. The market value includes the value of related goods sold by the service provider or included within the service offering. The parathyroid disease treatment market also includes sales of lanthanum carbonate, doxercalciferol, calcitriol, lanthanum carbonate, and parsabiv. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Parathyroid Disease Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses parathyroid disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for parathyroid disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Treatment: Calcimimetics; Bisphosphonates; Plicamycin; Hormone Replacement Therapy; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Calcimimetics: Cinacalcet; Etelcalcetide
2) By Bisphosphonates: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
3) By Plicamycin: Mithramycin (Plicamycin) Monotherapy; Combination Therapies Involving Plicamycin
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Adoption Of Calcimimetics And Bisphosphonates
4.2.2 Rising Preference For Parenteral Over Oral Administration In Severe Cases
4.2.3 Expansion Of Hospital And Specialty Care Settings
4.2.4 Growing Focus On Personalized Hormone Replacement Therapies
4.2.5 Integration Of Lifestyle And Nutritional Interventions In Treatment Plans
5. Parathyroid Disease Treatment Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Homecare
5.3 Specialty Centers
5.4 Clinics
5.5 Diagnostic Laboratories
6. Parathyroid Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Parathyroid Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Parathyroid Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Parathyroid Disease Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Parathyroid Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Parathyroid Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Parathyroid Disease Treatment Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Calcimimetics, Bisphosphonates, Plicamycin, Hormone Replacement Therapy, Other Treatments
9.2. Global Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Parenteral
9.3. Global Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.4. Global Parathyroid Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Specialty Centers, Other End-Users
9.5. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cinacalcet, Etelcalcetide
9.6. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Plicamycin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Parathyroid Hormone (PTH) Analogues, Surgery (Parathyroidectomy), Dietary Supplements, Lifestyle And Nutritional Interventions
10. Parathyroid Disease Treatment Market Regional And Country Analysis
10.1. Global Parathyroid Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Parathyroid Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Parathyroid Disease Treatment Market
12.1. China Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Parathyroid Disease Treatment Market
13.1. India Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Parathyroid Disease Treatment Market
14.1. Japan Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Parathyroid Disease Treatment Market
15.1. Australia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Parathyroid Disease Treatment Market
16.1. Indonesia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Parathyroid Disease Treatment Market
17.1. South Korea Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Parathyroid Disease Treatment Market
19.1. South East Asia Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Parathyroid Disease Treatment Market
20.1. Western Europe Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Parathyroid Disease Treatment Market
21.1. UK Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Parathyroid Disease Treatment Market
22.1. Germany Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Parathyroid Disease Treatment Market
23.1. France Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Parathyroid Disease Treatment Market
24.1. Italy Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Parathyroid Disease Treatment Market
25.1. Spain Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Parathyroid Disease Treatment Market
26.1. Eastern Europe Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Parathyroid Disease Treatment Market
27.1. Russia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Parathyroid Disease Treatment Market
28.1. North America Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Parathyroid Disease Treatment Market
29.1. USA Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Parathyroid Disease Treatment Market
31.1. South America Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Parathyroid Disease Treatment Market
32.1. Brazil Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Parathyroid Disease Treatment Market
33.1. Middle East Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Parathyroid Disease Treatment Market
34.1. Africa Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Parathyroid Disease Treatment Market Regulatory and Investment Landscape
36. Parathyroid Disease Treatment Market Competitive Landscape And Company Profiles
